SBIR: How to Win
When: Thursday, June 23, 2011, 9 - 11 a.m.
Where: 3rd Floor Teleclassroom, Scibelli Enterprise Center,
Registration Fee: $50
Two billion dollars in federal research grants annually - how much of that comes to western Mass.? Come hear top presenters share their insights into accessing these dollars through SBIR (Small Business Innovation Research) grants.
If your small business is engaged in scientific research & development (R&D), you may qualify for federal grants under the SBIR (Small Business Innovation Research) and the STTR (Small Business Technology Transfer) programs. SBIR and STTR programs encourage small businesses to undertake R&D projects that meet federal R&D objectives and have high potential for commercialization, if successful. A number of agencies award SBIR and STTR grants.
During this workshop we will look at:
- how a SBIR/STTR is similar to, and different from, other federally-funded R&D: marketing, proposal writing, winning Ph I, winning Ph II, transitioning to Ph III or commercialization.
- secrets of effective proposal writing: how to describe your idea, differentiate your proposal, and win the competition.
- the real story of technology transition and commercialization, agency by agency, and how this may affect your company and the future of SBIR/STTR.
- the current state of the program and potential for reauthorization after ten Congressional Continuing Resolutions since 2008.
- budget development & budget justification, resource pages and forms
- the grant assembly and electronic filing of the application
- raising capital by leveraging your grant review/score
- and, if time allows, we will review the art of obtaining a grant supplement.
Dr. Robert F.Weiss is the founder and Executive Vice President for Corporate Development of Physical Sciences Inc., a company engaged in research, development and manufacturing of electro-optical instrumentation for government and commercial applications. Dr. Weiss organized PSI's three commercial spin-outs; PSI Medical Products, Inc., Spectrum Diagnostix, Inc., and Confluent Photonics Corp., and served on the boards of all three until their acquisition by larger companies. He also founded and chairs the New England Innovation Alliance, an informal group that provides a forum for discussion of subjects of mutual interest to small high technology companies.
Dr. Weiss received his Doctor of Science in Engineering from NYU, a Masters' degree in Aeronautics and Astronautics from the MIT, where he has been a visiting lecturer, and a Bachelor of Aeronautical Engineering, also from NYU.
Dennis Guberski, a geneticist, is the founder and CEO of BRM/Biomere (BioMedical Research Models). Mr. Guberski founded BRM in 1996 and currently serves as the Principal Investigator on the $4.9 million type 1 diabetes Pre-clinical Testing Program for T1D RAID support. He received his MS in Genetics from University of Massachusetts, Amherst, MA.
Mr. Guberski has raised ~ $5 million in equity and successfully leveraged this investment into more than $18 million in USPHS grants and contracts while driving pre-clinical CRO operations into profitability. BRM's track record is > 60% success. To date more than 17MM in USPHS grants and contract have been obtained. They were the first company in the USA awarded a $1MM Phase 1 SBIR grant and currently have a 2.6MM phase 2 grant.
You may register online at www.msbdc.org/wmass/training.html or call 413.737.6712.